// App-Quantinova.ai

241 : D-Dimer Improves Risk Prediction of Venous Thromboembolism in Patients with Multiple Myeloma

Researchers

Presenter

  • Kristen M. Sanfilippo

Principal Investigators

  • Mark A Fiala

  • Harsha Tathireddy

  • Dan Feinberg

  • Ravi Vij

  • Brian F. Gage

Medical Centers

  • Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO.

  • St. Louis Veterans Affairs Medical Center Research Service, Saint Louis, MO

  • Washington University School of Medicine, St. Louis, MO

  • St Joseph Memorial Hospital, Southern Illinois Healthcare, Murphysboro, IL

  • Division of Oncology, Washington University School of Medicine, St. Louis, MO

  • Washington University School of Medicine, St. Louis, MO

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Multiple Myeloma

Biomarkers

  • D-dimer

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A